Senior Scientist (Drug Metabolism & Pharmacokinetics)

The Drug Metabolism & Pharmacokinetics (DMPK) department at Genentech is seeking a highly motivated leader who will be supporting small molecule projects in discovery and development. The DMPK group is dedicated to enabling the discovery, development and commercialization of safe and effective medicines by elucidating the absorption, distribution, metabolism, excretion and pharmacokinetic properties of traditional small molecule and emerging modality drug candidates. We accomplish this through the application of state-of-the-art technologies and sciences of bioanalysis, drug metabolism, drug transport and pharmacokinetics. The DMPK group works in close partnership with disciplines such as medicinal chemistry, pharmacology, toxicology, pharmaceutical sciences, clinical pharmacology and regulatory to optimize leads, select clinical candidates, conduct preclinical development studies, support clinical evaluation and contribute to IND and NDA filings. Opportunity The individual would lead the DMPK strategy, design and oversee non-clinical studies in a highly collaborative project team environment. Specifically, the following activities as part of their role: Serve as the DMPK representative on multidisciplinary project teams and communicate recommendations to project teams. Lead DMPK strategy and author or review relevant sections of regulatory briefing packages/filings. Design, oversee, interpret and integrate in vitro and in vivo ADME, PK and translate nonclinical data into human PK and dose predictions. Identify DMPK-related risks, and develop mitigation strategies. Who You Are PhD in pharmacokinetics, drug metabolism, pharmaceutical sciences or related discipline. At least 2 years of relevant pharmaceutical industry experience as a DMPK project leader. Strong knowledge of ADME, PK, and the integration of DMPK data into discovery and development decisions. Experience designing, interpreting and integrating nonclinical DMPK studies. Ability to communicate complex scientific data, uncertainties and recommendations clearly to multidisciplinary teams and senior stakeholders. Preferred Experience Experience as a member/leader of multi-functional project teams supporting diverse modalities (small/large molecules, peptides, degraders, conjugates, etc.), in particular, those outside Lipinski's Rule-of-5. Experience supporting programs through candidate selection, IND-enabling development, clinical development or regulatory interactions. Hands-on experience with PK/PD modeling and/or PBPK modeling using relevant modeling and simulation platforms are highly desired. Together, we will advance along the whole patient journey with the aspiration to prevent, stop and cure diseases. This position does offer domestic relocation. The expected salary range for this position based on the primary location of San Francisco, CA is 124,300.00 - 230,900.00 USD. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance. This position also qualifies for the benefits detailed at the link provided below. Benefits Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws. If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants. Who We Are Genentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The next step is yours. #J-18808-Ljbffr F. Hoffmann-La Roche AG